摘要:
Telechelic polyolefin of formula(I) and its derivatives: CH2═CH—(CH2)p-A-Z (I) wherein: A represents a (co)polymer comprising at least 95 mol % of (CH2—CH2) units; Z is selected from the group comprising halogens, thiols and their derivatives, azides, amines, alcohols, the carboxylic acid function, isocyanates, silanes, phosphorous derivatives, dithioesters, dithiocarbamates, dithiocarbonates, trithiocarbonates, alkoxyamines, the vinyl function, dienes, and the group —A—(CH2)p-CH═CH2; p is a whole number between 1 and 20, most advantageously between 6 and 9.
摘要:
A coordination complex having a physiologically acceptable pKa includes a metal and a biologically active agent. The pKa of the coordination complex is less than the pKa of the biologically active agent. A pharmaceutical solution for treating a patient includes a coordination complex and water, wherein the coordination complex is at least partially soluble in the water at physiological pH and in a therapeutically efficacious concentration. A method for treating a patient includes administering a pharmaceutical solution including a coordination complex and water to a patient in need of a biologically active agent.
摘要:
A coordination complex having a physiologically acceptable pKa includes a metal and a biologically active agent. The pKa of the coordination complex is less than the pKa of the biologically active agent. A pharmaceutical solution for treating a patient includes a coordination complex and water, wherein the coordination complex is at least partially soluble in the water at physiological pH and in a therapeutically efficacious concentration. A method for treating a patient includes administering a pharmaceutical solution including a coordination complex and water to a patient in need of a biologically active agent.
摘要:
Compositions of stabilized forms of organometallic reagents, methods of preparing the stabilized forms, and methods of using the stabilized forms, are provided. Stabilized organometallic reagent compositions of the invention are sorbent solids permeated by the organometallic reagent. The reagent can be a Grignard reagent, a Reformatsky reagent, a zinc reagent of the type RZnX, R2Zn, Ar2Zn, R3ZnM, Ar3ZnM, and the like, an organolithium reagent such as n-butyllithium, a organocopper reagent, or other reactive, potentially pyrophoric reagent. The compositions are solids that can be weighed and dispensed in ambient air without requiring inert gas blanketing. The compositions can be prepared by contacting the sorbent solid, which can be silica, an alkyl silica, alumina, or other non-reactive sorbent solid with a solution of the organometallic reagent in a non-reactive solvent, then, removing the solvent, such as under vacuum. The stabilized composition can be used by extracting the organometallic reagent from the composition with a non-reactive solvent and contacting the solution with a reactant.
摘要:
The present invention relates to the process for the conversion of 1-benzyl-3-hydroxymethyl-1H-indazole according to formula (II), to the 1-benzyl-3-hydroxylmethyl-1H-indazole according to formula (I).
摘要:
There is provided a method for producing a tris(perfluoroalkanesulfonyl)methide acid salt represented by formula [1], including the steps of (a) reacting a methylmagnesium halide represented by formula [2] with a perfluoroalkanesulfonyl fluoride represented by formula [3], thereby obtaining a reaction mixture; and (b) directly reacting the obtained reaction mixture with at least one selected from the group consisting of alkali metal halides, quaternary ammonium salts, and quaternary phosphonium salts. By this method, it is possible to easily produce the target methide acid salt with high yield.
摘要:
A method of treating a human subject having a condition responsive to valproic acid therapy, includes administering to the subject an effective amount of a metal-based ternary complex of valproic acid with nitrogen donor ligands, in particular with diimines or diamines.